Published in PLoS One on November 08, 2012
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers (1983) 99.69
Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B Condens Matter (1988) 93.32
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol (1973) 47.81
GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput (2008) 34.90
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem (2004) 15.51
Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (2002) 12.29
Essential dynamics of proteins. Proteins (1993) 11.56
Quantum mechanical continuum solvation models. Chem Rev (2005) 10.95
Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem (2006) 8.75
Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem (2004) 7.96
Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model. J Comput Chem (2003) 7.72
The many roles of computation in drug discovery. Science (2004) 5.66
Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer (2006) 5.58
Folding funnels and binding mechanisms. Protein Eng (1999) 3.25
Molecular dynamics: survey of methods for simulating the activity of proteins. Chem Rev (2006) 3.18
Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev (1999) 2.96
Implications of protein flexibility for drug discovery. Nat Rev Drug Discov (2003) 2.83
Progress in matrix metalloproteinase research. Mol Aspects Med (2008) 2.51
Structural basis for the highly selective inhibition of MMP-13. Chem Biol (2005) 2.33
The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta (2004) 2.30
Direct calculation of the binding free energies of FKBP ligands. J Chem Phys (2005) 1.88
MMPs as therapeutic targets--still a viable option? Semin Cell Dev Biol (2007) 1.78
Theory of biomolecular recognition. Curr Opin Struct Biol (1998) 1.76
Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie (2005) 1.76
Combining docking and molecular dynamic simulations in drug design. Med Res Rev (2006) 1.70
Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol (2001) 1.67
Managing protein flexibility in docking and its applications. Drug Discov Today (2009) 1.51
Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects. J Biol Chem (2007) 1.37
NMR relaxation studies of the role of conformational entropy in protein stability and ligand binding. Acc Chem Res (2001) 1.37
Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. Biochemistry (2009) 1.34
Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs. Biochimie (2005) 1.26
Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats. Arthritis Rheum (2003) 1.26
Preclinical and clinical studies of MMP inhibitors in cancer. Ann N Y Acad Sci (1999) 1.23
Complexity and simplicity of ligand-macromolecule interactions: the energy landscape perspective. Curr Opin Struct Biol (2002) 1.18
Crystal structures of MMPs in complex with physiological and pharmacological inhibitors. Biochimie (2005) 1.15
Independent-Trajectories Thermodynamic-Integration Free-Energy Changes for Biomolecular Systems: Determinants of H5N1 Avian Influenza Virus Neuraminidase Inhibition by Peramivir. J Chem Theory Comput (2009) 1.11
Metalloproteinases: their role in arthritis and potential as therapeutic targets. Expert Opin Ther Targets (2003) 1.11
Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors. Curr Pharm Des (2007) 1.08
A rationalization of the acidic pH dependence for stromelysin-1 (Matrix metalloproteinase-3) catalysis and inhibition. J Biol Chem (2000) 1.02
Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8). J Med Chem (2009) 1.01
Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors. Bioorg Med Chem Lett (2005) 1.00
Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12. J Mol Biol (2004) 1.00
Insight into the structural determinants for selective inhibition of matrix metalloproteinases. Drug Discov Today (2007) 0.98
Impact of mobility on structure-based drug design for the MMPs. J Am Chem Soc (2002) 0.97
Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis. J Med Chem (2008) 0.94
Protein flexibility is an important component of structure-based drug discovery. Curr Pharm Des (2002) 0.94
Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes. J Mol Biol (1999) 0.94
Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors. Bioorg Med Chem Lett (2009) 0.94
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors. J Mol Recognit (2010) 0.93
Molecular dynamics simulations of metalloproteinases types 2 and 3 reveal differences in the dynamic behavior of the S1' binding pocket. Curr Pharm Des (2007) 0.90
Computational Analysis of the Mechanism and Thermodynamics of Inhibition of Phosphodiesterase 5A by Synthetic Ligands. J Chem Theory Comput (2007) 0.90
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis. Bioorg Med Chem Lett (2009) 0.89
Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors. Chem Biol Drug Des (2011) 0.86
Molecular dynamics simulations of matrix metalloproteinase 2: role of the structural metal ions. Biochemistry (2007) 0.82
Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3). Eur J Biochem (2001) 0.81
Computational study of the catalytic domain of human neutrophil collagenase. specific role of the S3 and S'3 subsites in the interaction with a phosphonate inhibitor. J Comput Aided Mol Des (2002) 0.81
Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallography. J Biomol NMR (1996) 0.79
Insights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculations. PLoS One (2011) 0.77
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8. Bioorg Med Chem Lett (2005) 0.92
Gold-catalyzed reactions of 2-alkynyl-phenylamines with alpha,beta-enones. J Org Chem (2005) 0.91
Natural D240G Toho-1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43. J Antimicrob Chemother (2008) 0.88
Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates. J Med Chem (2006) 0.87
Dynamical aspects of TEM-1 beta-lactamase probed by molecular dynamics. J Comput Aided Mol Des (2005) 0.85
Design, modelling, synthesis and biological evaluation of peptidomimetic phosphinates as inhibitors of matrix metalloproteinases MMP-2 and MMP-8. Bioorg Med Chem (2005) 0.85
Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors. Bioorg Med Chem (2013) 0.85
Folding propensity and biological activity of peptides: the effect of a single stereochemical isomerization on the conformational properties of bombinins in aqueous solution. Biopolymers (2008) 0.84
Theoretical characterization of carbon monoxide vibrational spectrum in sperm whale myoglobin distal pocket. Biophys J (2007) 0.84
Biphenyl sulfonylamino methyl bisphosphonic acids as inhibitors of matrix metalloproteinases and bone resorption. ChemMedChem (2011) 0.84
The role of arginine 38 in horseradish peroxidase enzyme revisited: a computational investigation. Biophys Chem (2009) 0.83
The reversible opening of water channels in cytochrome c modulates the heme iron reduction potential. J Am Chem Soc (2012) 0.83
AMBER force field implementation of the boronate function to simulate the inhibition of beta-lactamases by alkyl and aryl boronic acids. Eur J Med Chem (2005) 0.82
Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus. Pathog Glob Health (2012) 0.81
Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors. ChemMedChem (2013) 0.80
Structural insight into peroxisome proliferator-activated receptor gamma binding of two ureidofibrate-like enantiomers by molecular dynamics, cofactor interaction analysis, and site-directed mutagenesis. J Med Chem (2010) 0.80
Molecular dynamics simulation of Leishmania major surface metalloprotease GP63 (leishmanolysin). Proteins (2006) 0.79
Free-energy profile for CO binding to separated chains of human and Trematomus newnesi hemoglobin: insights from molecular dynamics simulations and perturbed matrix method. J Phys Chem B (2010) 0.79
Conformational analysis and UV/Vis spectroscopic properties of a rotaxane-based molecular machine in acetonitrile dilute solution: when simulations meet experiments. Phys Chem Chem Phys (2010) 0.78
Theoretical modeling of enzyme reactions: the thermodynamics of formation of compound 0 in horseradish peroxidase. J Phys Chem B (2008) 0.78
Role of the amino sugar in the DNA binding of disaccharide anthracyclines: crystal structure of the complex MAR70/d(CGATCG). Bioorg Med Chem (2005) 0.78
Computational study of the reaction of N(2D) atoms with CH2F radicals: an example of a barrier-free reaction involving very high internal energies. J Chem Phys (2005) 0.78
Simulation of the amide I infrared spectrum in photoinduced peptide folding/unfolding transitions. J Phys Chem B (2013) 0.77
Ground and excited electronic state thermodynamics of aqueous carbon monoxide: a theoretical study. J Chem Phys (2005) 0.77
Cyclochiral resorcin[4]arenes as effective enantioselectors in the gas phase. J Mass Spectrom (2012) 0.77
Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors. Eur J Med Chem (2007) 0.77
Does adsorption at hydroxyapatite surfaces induce peptide folding? Insights from large-scale B3LYP calculations. J Am Chem Soc (2012) 0.77
Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors. Curr Drug Targets (2015) 0.77
Theoretical modeling of vibroelectronic quantum states in complex molecular systems: solvated carbon monoxide, a test case. J Chem Phys (2005) 0.77
Theoretical study of alpha-84 phycocyanobilin chromophore from the thermophilic cyanobacterium Synechococcus elongatus. J Phys Chem B (2007) 0.77
Peptides containing 4-amino-1,2-dithiolane-4-carboxylic acid (Adt): conformation of Boc-Adt-Adt-NHMe and NH...S interactions. J Pept Sci (2005) 0.77
Synthesis, SAR, and biological evaluation of alpha-sulfonylphosphonic acids as selective matrix metalloproteinase inhibitors. ChemMedChem (2009) 0.77
alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs. Bioorg Med Chem (2006) 0.77
The effect of protein conformational flexibility on the electronic properties of a chromophore. Biophys J (2003) 0.77
Modeling of chemical reactions in micelle: water-mediated keto-enol interconversion as a case study. J Phys Chem B (2011) 0.77
Conformational and electronic properties of a microperoxidase in aqueous solution: a computational study. Chemphyschem (2005) 0.77
A few key residues determine the high redox potential shift in azurin mutants. Org Biomol Chem (2015) 0.76
Structural and dynamical properties of KTS-disintegrins: A comparison between Obtustatin and Lebestatin. Biopolymers (2013) 0.76
Structure-Activity Relationship of novel phenylacetic CXCR1 inhibitors. Bioorg Med Chem Lett (2009) 0.76
Non-Zinc-Binding Inhibitors of MMP-13: GRID-Based Approaches to Rationalize the Binding Process. Curr Top Med Chem (2016) 0.76
Structural modifications of ionic liquid surfactants for improving the water dispersibility of carbon nanotubes: an experimental and theoretical study. Phys Chem Chem Phys (2011) 0.76
Molecular dynamics simulation of the interaction between the complex iron-sulfur flavoprotein glutamate synthase and its substrates. Protein Sci (2004) 0.76
New insight into the IR-spectra/structure relationship in amyloid fibrils: a theoretical study on a prion peptide. J Am Chem Soc (2011) 0.75
Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors. J Amino Acids (2013) 0.75
Computational study on compound I redox-active species in horseradish peroxydase enzyme: conformational fluctuations and solvation effects. J Phys Chem B (2010) 0.75
Essential dynamics for the study of microstructures in liquids. J Comput Chem (2014) 0.75
Liposome destabilization by a 2,7-diazapyrenium derivative through formation of transient pores in the lipid bilayer. Small (2010) 0.75
Theoretical characterization of electronic states in interacting chemical systems. J Chem Phys (2009) 0.75
On the effect of a point mutation on the reactivity of CuZn superoxide dismutase: a theoretical study. J Phys Chem B (2006) 0.75
Theoretical characterization of temperature and density dependence of liquid water electronic excitation energy: comparison with recent experimental data. J Chem Phys (2008) 0.75
Theoretical-computational modelling of infrared spectra in peptides and proteins: a new frontier for combined theoretical-experimental investigations. Curr Opin Struct Biol (2010) 0.75
Modelling spin-forbidden reactions: recombination of carbon monoxide with iron tetracarbonyl. Faraday Discuss (2003) 0.75
Theoretical modeling of UV-Vis absorption and emission spectra in liquid state systems including vibrational and conformational effects: the vertical transition approximation. J Chem Phys (2013) 0.75
Theoretical-computational modeling of photo-induced charge separation spectra and charge recombination kinetics in solution. Phys Chem Chem Phys (2014) 0.75
Fast stereoselective reactions in electrosprayed Co(II)/neurotransmitter nanodroplets. Chem Commun (Camb) (2008) 0.75
Effects of biphenyl sulfonylamino methyl bisphosphonic acids on Porphyromonas gingivalis and cytokine secretion by oral epithelial cells. Med Chem (2013) 0.75
Can a synthetic thread act as an electrochemically switchable molecular device? Chem Commun (Camb) (2008) 0.75
P-113 Peptide: New experimental evidences on its biological activity and conformational insights from molecular dynamics simulations. Biopolymers (2014) 0.75
Charge transfer equilibria of aqueous single stranded DNA. Phys Chem Chem Phys (2009) 0.75
A fast redox-induced switching mechanism in a conformationally controllable molecular thread in solution. Phys Chem Chem Phys (2010) 0.75
Theoretical modeling of the valence UV spectra of 1,2,3-triazine and uracil in solution. Phys Chem Chem Phys (2006) 0.75
A computational study of the reaction of ground-state nitrogen atoms with chloromethyl radicals. J Phys Chem A (2005) 0.75
Ac-tLeu-Asp-H is the minimal and highly effective human caspase-3 inhibitor: biological and in silico studies. Amino Acids (2014) 0.75
On the structural affinity of macromolecules with different biological properties: molecular dynamics simulations of a series of TEM-1 mutants. Biochem Biophys Res Commun (2013) 0.75
A general theoretical model for electron transfer reactions in complex systems. Phys Chem Chem Phys (2011) 0.75